在类风湿性关节炎中治疗甲索酸骨质病
Olga Dorota Lotkowska1, Sabine Adler2,3, Armin Zgraggen2
1Clinic for Rheumatology and Immunology, Kantonsspital Aarau, Aarau, Switzerland. olga.lotkowska@gmail.com.
Rheumatology international
|December 8, 2025
概括
甲甲酸 (MTX) 可以导致骨问题,如骨折在成年人与类风湿性疾病. 停止使用MTX导致MTX相关骨质病症患者的快速改善.
科学领域:
- 类风湿病学 类风湿病学
- 骨的新陈代谢 骨的新陈代谢
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基 (MTX) 是一种常见的治疗炎症性类风湿性疾病.
- 与MTX相关的骨质炎,一种影响骨矿物质密度和骨折风险的副作用,在低至中等剂量的成年人中受到争论.
- 与MTX相关的骨质病的确切原因和临床重要性尚未完全理解.
研究的目的:
- 在患有类风湿性疾病的成年患者中研究MTX相关的骨质病.
- 审查MTX相关骨质病的临床和放射性特征.
- 评估MTX对骨矿物质密度和骨折风险的影响.
主要方法:
- 四名女性患者的病例系列,患有类风湿性关节炎 (RA),呈现压力骨折.
- 系统性文献综述,重点关注MTX相关骨质病的临床和放射性特征.
- 分析MTX对骨矿物质密度和骨折风险的影响.
主要成果:
- 四名RA患者经历了骨和骨的压力骨折,有些人有多重骨折.
- 患者在停止使用MTX后显示出快速的临床改善,这表明MTX相关的骨质病.
- 审查强调了常见的临床和成像发现,包括带状或状骨折.
结论:
- 与MTX相关的骨质炎是成年人患有类风湿性疾病,特别是RA的压力骨折的潜在原因.
- 诊断需要仔细排除其他骨折原因,并考虑停止MTX治疗.
- 需要进一步的研究,以充分阐明MTX相关骨质病变的病变发生和临床意义.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
01:29Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
457
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
457
01:21Rheumatic Heart Disease III: Medical Management
267
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
267
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K